Mapping of Sp1 regulation sites in the promoter of the human α1-proteinase inhibitor gene

Journal of Cellular Biochemistry

Volumn 85, Issue 3, 2002, Pages 482-489

  Maruyama, Yasuhiro ^a   Li, Yuhong ^a   Zhang, Yan ^a   Wang, Xinping ^b   Sugar, Joel ^b   Yue, Beatrice Y J T ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

1 proteinase inhibitor; Cornea; Deletion mutants; Promoter; Site directed mutagenesis; Sp1

Indexed keywords

ALPHA 1 ANTITRYPSIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA STROMA; DELETION MUTANT; DNA SEQUENCE; DNA VECTOR; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATOCONUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ADULT; ALPHA 1-ANTITRYPSIN; BINDING SITES; CELLS, CULTURED; CHILD; CORNEA; GENE EXPRESSION REGULATION; HUMANS; KERATOCONUS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; STROMAL CELLS;

VECTORS;

EID: 0036240822     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10149     Document Type: Article

References (36)

1. Transcription factor Sp1 activates involucrin promoter activity in nonepithelial cell
2. Transcriptional initiation is controlled by upstream GC-box interactions in a TATA-less promoter
3. Molecular basis of α1-antitrypsin deficiency
4. Cell-specific expression of a transfected human α1-antitrypsin gene
5. Keratoconus: I. Biochemical studies of normal and keratoconus corneas
6. Cis- and trans-acting elements responsible for the cell-specific expression of the human α1-antitrypsin gene
7. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II
8. Pulmonary emphysema and α1-antitrypsin deficiency
9. Constitutive and modulated expression of the human α1 antitrypsin gene
10. Keratoconus and related noninflammatory corneal disorders
11. Protease inhibitors in plasma
12. Involvement of Sp1 elements in the promoter activity of the α1-proteinase inhibitor gene
13. Complete sequence of the cDNA for human α1-antitrypsin and the gene for the S variant
14. Contemporary management of keratoconus
15. DNA looping and Sp1 multimer links: A mechanism for transcriptional synergism and enhancement
16. The Sp1 transcription factor regulates cell type-specific transcription of MUC1
17. Negative regulatory role of Sp1 in metal responsive element-mediated transcriptional activation
18. α1-Antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects
19. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism
20. The human α1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes
21. Expression of the α1-proteinase inhibitor gene in human monocytes and macrophages
22. Gene regulation by proteins acting nearby and at a distance
23. Keratoconus
24. Lysosomal enzyme abnormalities in keratoconus
25. α1-Proteinase inhibitor levels in keratoconus
26. α2-Macroglobulin levels in normal human and keratoconus corneas
27. Cirrhosis associated with α1-antitrypsin deficiency: A previously unrecognized inherited disorder
28. Human plasma protease inhibitors
29. Corneal synthesis of α1-proteinase inhibitor (α1-antitrypsin)
30. Interaction of Ap1, Ap2, and Sp1 with the regulatory regions of the human pro-α1(I) collagen gene
31. Cathepsin G, acid phosphatase, and α1-proteinase inhibitor messenger RNA levels in keratoconus corneas
32. Expression of transcription factors in keratoconus, a cornea-thinning disease
33. Studies of corneas in vivo and in vitro
34. Heterogeneity in keratoconus: Possible biochemical basis
35. RNA metabolism in cultures of corneal stromal cells from patients with keratoconus
36. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus